YU78695A - Derivati piperazina, lekovi koji sadrže dva jedinjenja, njihova primena i postupci za njihovo pripremanje - Google Patents

Derivati piperazina, lekovi koji sadrže dva jedinjenja, njihova primena i postupci za njihovo pripremanje

Info

Publication number
YU78695A
YU78695A YU78695A YU78695A YU78695A YU 78695 A YU78695 A YU 78695A YU 78695 A YU78695 A YU 78695A YU 78695 A YU78695 A YU 78695A YU 78695 A YU78695 A YU 78695A
Authority
YU
Yugoslavia
Prior art keywords
compounds
preparation
medecines
derivates
piperazin
Prior art date
Application number
YU78695A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
Helmut Pieper
Volkhard Austel
Frank Himmelsbach
Gunter Linz
Brian Guth
Johannes Weisenbergen
Original Assignee
Dr. Karl Thomae Gmbh.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr. Karl Thomae Gmbh. filed Critical Dr. Karl Thomae Gmbh.
Publication of YU78695A publication Critical patent/YU78695A/sh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
YU78695A 1994-12-23 1995-12-21 Derivati piperazina, lekovi koji sadrže dva jedinjenja, njihova primena i postupci za njihovo pripremanje YU78695A (sh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19944446301 DE4446301A1 (de) 1994-12-23 1994-12-23 Piperazinderivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
DE19526678A DE19526678A1 (de) 1994-12-23 1995-07-21 Piperazinderivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
DE1995133639 DE19533639A1 (de) 1994-12-23 1995-09-12 Piperazinderivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
YU78695A true YU78695A (sh) 1998-09-18

Family

ID=6536919

Family Applications (1)

Application Number Title Priority Date Filing Date
YU78695A YU78695A (sh) 1994-12-23 1995-12-21 Derivati piperazina, lekovi koji sadrže dva jedinjenja, njihova primena i postupci za njihovo pripremanje

Country Status (5)

Country Link
KR (1) KR987000970A (es)
CO (1) CO4700299A1 (es)
DE (3) DE4446301A1 (es)
PE (1) PE63996A1 (es)
YU (1) YU78695A (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6069143A (en) * 1994-12-20 2000-05-30 Smithkline Beecham Corporation Fibrinogen receptor antagonists
US5889006A (en) * 1995-02-23 1999-03-30 Schering Corporation Muscarinic antagonists
US5990107A (en) * 1996-06-28 1999-11-23 Merck & Co., Inc. Fibrinogen receptor antagonist prodrugs
US5854245A (en) * 1996-06-28 1998-12-29 Merck & Co., Inc. Fibrinogen receptor antagonists
AU721130B2 (en) * 1996-06-28 2000-06-22 Merck & Co., Inc. Fibrinogen receptor antagonists
US5932582A (en) * 1996-06-28 1999-08-03 Merck & Co., Inc. Fibrinogen receptor antagonist prodrugs
US5945545A (en) * 1996-12-13 1999-08-31 Merck & Co., Inc. Fibrinogen receptor antagonists
EP1070712A4 (en) * 1998-04-09 2005-01-05 Meiji Seika Kaisha NITROGEN-CONTAINING HETEROCYCLES WITH ANTI-BLOOD INFLAMMATION AND THEIR MEDICAL USE

Also Published As

Publication number Publication date
DE19533639A1 (de) 1997-03-13
KR987000970A (ko) 1998-04-30
CO4700299A1 (es) 1998-12-29
PE63996A1 (es) 1997-01-24
DE4446301A1 (de) 1996-06-27
DE19526678A1 (de) 1997-01-23

Similar Documents

Publication Publication Date Title
MEP58708A (en) Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
MEP45508A (en) Bicyclic heterocycles, medicaments containing these compounds, their use and methods for the production thereof
MEP45608A (en) Bicyclic heterocycles, pharmaceutical compositions containing these compounds, and processes for preparing them
MEP59508A (en) Quinazoline derivatives, medicaments containing said compounds, their utilization and method for the production thereof
MEP45308A (en) [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
BR0314393A (pt) Piperazinas heterocìclicas substituìdas para o tratamento de esquizofrenia
YU53298A (en) Aryl pyrimidine derivatives
YU49195A (sh) 5-člani heteroaril-oksazolidinoni, njihova upotreba za dobijanje lekova kao i lekovi koji ih sadrže
MEP51408A (en) Selected cgrp antagonists, method for production and use thereof as medicament
EA200501516A1 (ru) Производные 2,3,6-тризамещённого-4-пиримидона
BR0211284A (pt) Derivados de 1-fenilsulfonil-1,3-dihidro-2h-indol-2-ona, a respectiva preparação e a respectiva aplicação em terapêutica
ME00459B (me) Aril fuzirana azapoliciklična jedinjenja
NO972881L (no) Piperazinderivater, legemidler som inneholder disse, anvendelse derav og fremgangsmåte for deres fremstilling
ES2163295T3 (es) Derivados de imidazol y su uso como inhibidores de la farnesil-protein-transferasa.
RU94038064A (ru) Производные пиперазина и пиперидина, их применение в качестве противопсихотических средств, способ их получения фармацевтическая композиция
BRPI0015254C1 (pt) compostos derivados de carbamoiloxialquil-azólio, seu uso, bem como composição farmacêutica compreendendo os mesmos.
HUP0002272A2 (hu) Piperazinszármazékok, eljárás előállításukra, e vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk
YU21701A (sh) Farmaceutska sredstva za lečenje parkinsonove bolesti, poremećaja nekontrolisane hiperaktivnosti (adhd) i mikroadenoma
YU78695A (sh) Derivati piperazina, lekovi koji sadrže dva jedinjenja, njihova primena i postupci za njihovo pripremanje
BRPI0418255A (pt) derivados de piperazina e piperidina n-substituìdos
ES2084996T3 (es) Piperazinas sustituidas utiles como agentes para el sistema nervioso central.
BR0103210A (pt) Derivados de azabicicloalcano e suas utilizações terapêuticas
FR2817256B1 (fr) Derives de l'acides 4-hydroxybutanoique et de son homologue superieur comme ligands des recepteurs du gamma- hydroxybutyrate (ghb), compositions pharmaceutiques les contenant et utilisations pharmaceutiques
YU44301A (sh) 5ht1 antagonisti za antidepresantnu terapiju
DE69725457D1 (de) Piperazinderivate als neurokinin-antagonisten